SGLT-2 inhibitors show mixed results after heart attack
While the composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack
Apr 8, 2024
0
0
While the composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack
Apr 8, 2024
0
0
About 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. There are limited treatments to prevent or slow that development.
Apr 8, 2024
0
0
A new meta-analysis shows sodium glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of major adverse cardiovascular events in patients with either diabetes at high risk of atherosclerotic cardiovascular disease (ASCVD), ...
Apr 8, 2024
0
0
Findings from a new study by public health researchers at the U of A suggest that people older than 50 might want to consult a doctor before taking up pickleball, the tennis-like sport that has grown in popularity over the ...
Apr 5, 2024
0
22
Cardiovascular diseases, including myocardial infarction and stroke, are the world's leading cause of death, claiming around 18 million lives a year. This observation justifies the adage that you are only as old as your arteries ...
Apr 3, 2024
0
7
Research into the protective effects of two anti-inflammatory molecules following a heart attack has found that two proteins reduce the inflammatory response and scarring within the injured heart. The study is published in ...
Mar 22, 2024
0
2
A study by Allison Appleton, Mark Kuniholm and Elizabeth Vásquez in the School of Public Health's Department of Epidemiology and Biostatistics is the first to establish a connection between physical and sexual abuse and ...
Mar 21, 2024
0
3
A new Viewpoint article published in the Journal of the American Medical Association (JAMA), titled " Use of Lecanemab for Patients with Cardiovascular Disease—The Challenge of Uncertainty," advocates for additional research ...
Mar 18, 2024
0
1
For patients with newly diagnosed hyperthyroidism, surgery is associated with lower risks for major adverse cardiovascular events (MACE) and all-cause mortality, according to a study published online March 4 in JAMA Network ...
Mar 13, 2024
0
0
Hyperthyroidism, or overactive thyroid, happens when your thyroid gland makes more thyroid hormones than your body needs. Excessive thyroid hormones from hyperthyroidism elevate cardiovascular risks.
Mar 4, 2024
0
0